SBI Healthcare Opportunities Fund - IDCW - Regular Plan

  • Previous Nav

  • Net Change on 22-05-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 1.88 -0.36 51.37 15.65 25.35 16.52
S&P BSE Health Care - TRI 3.07 0.38 56.48 14.28 22.80 15.33
S&P BSE SENSEX - TRI 1.08 1.75 21.40 15.12 15.04 13.63

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 51.37 15.65 25.35 2.01 2,667.21
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 56.61 14.69 24.92 1.82 7,132.82
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option Jul 13, 2018 60.70 16.42 26.24 1.95 3,834.82
DSP Healthcare Fund - Regular Plan - IDCW Nov 30, 2018 52.36 16.49 27.30 2.00 2,343.94
Mirae Asset Healthcare Fund Regular IDCW Jul 02, 2018 52.91 14.04 25.72 1.99 2,236.01
UTI Healthcare Fund - Regular Plan - IDCW Aug 25, 1999 53.44 12.41 23.03 2.33 943.34

Fund Holdings as on 30-April-2024

  • Sun Pharmaceutical Industries Ltd.

  • Max Healthcare Institute Ltd.

  • Cipla Ltd.

  • Divi's Laboratories Ltd.

  • Lonza Group

  • Mankind Pharma Ltd.

  • Aether Industries Ltd.

  • Jupiter Life Line Hospitals Ltd.

  • Lupin Ltd.

  • Aurobindo Pharma Ltd.

  • Krishna Institute of Medical Sciences Ltd.

  • Global Health Ltd.

  • Rainbow Children's Medicare Ltd.

  • Abbott India Ltd.

  • Gland Pharma Ltd.

  • Fortis Healthcare Ltd.

  • Torrent Pharmaceuticals Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Aster DM Healthcare Ltd.

  • Zydus Lifesciences Ltd.

  • Alkem Laboratories Ltd.

  • TREPS

  • Laurus Labs Ltd.

  • Gufic Biosciences Ltd.

  • Dr. Lal Path labs Ltd.

  • Vijaya Diagnostic Centre Ltd.

  • Net Receivable / Payable

  • Shreno Ltd.

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

View More

Fund Manager

  • Education:B.E (Electronics),MBA (Finance),C.F.A(USA) Level III candidate
  • Experience:6 years
  • Basic Details:Mr. Desai has close to 6 years of work experience with over 3 years of experience in Indian capital markets. He has been associated with SBI Funds Management Private Limited from May 2008. Prior to join SBI Funds Management Pvt. Ltd. he was a lecturer in Electronics Department with D J Sanghvi College of Engineering, Mumbai.
  • Funds Managed:
  • SBI Healthcare Opportunities Fund
  • SBI Magnum Global Fund
  • SBI Healthcare Opportunities Fund
  • SBI Magnum Global Fund

Most Recent Dividend

  • 16/03/2018

  • 30/01/2015

  • 04/01/2005

  • 06/09/2004

  • 22/09/2003

  • Cash

  • CRISIL A

  • Equity

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 03-Jul-1999 and currently has an AUM of ₹2,667.21 crore. SBI Healthcare Opportunities Fund is benchmarked against S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended down ₹-0.98(-0.45%)yesterday to ₹218.4003.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai and Pradeep Kesavan.

Fund House Contact

191, Maker Tower 'E' Cuffe Parade Mumbai - 400 005

022 - 22180221-27
022 - 22189663
www.sbimf.com